Cody A Siciliano1, Erin S Calipari1,2, Jordan T Yorgason1, David M Lovinger3, Yolanda Mateo3, Vanessa A Jimenez4, Christa M Helms4, Kathleen A Grant4, Sara R Jones5. 1. Department of Physiology and Pharmacology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA. 2. Fishberg Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. 3. Laboratory for Integrative Neuroscience, Section on Synaptic Pharmacology, National Institute on Alcohol Abuse and Alcoholism, NIH, Rockville, MD, USA. 4. Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, 97006, USA. 5. Department of Physiology and Pharmacology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC, 27157, USA. srjones@wakehealth.edu.
Abstract
RATIONALE: Hypofunction of striatal dopamine neurotransmission, or hypodopaminergia, is a consequence of excessive ethanol use and is hypothesized to be a critical component of alcoholism, driving alcohol intake in an attempt to restore dopamine levels; however, the neurochemical mechanisms involved in these dopaminergic deficiencies are not fully understood. OBJECTIVE: Here we examined the specific dopaminergic adaptations that produce hypodopaminergia and contribute to alcohol use disorders using direct, sub-second measurements of dopamine signaling in nonhuman primates following chronic ethanol self-administration. METHODS: Female rhesus macaques completed 1 year of daily (22 h/day) ethanol self-administration. Subsequently, fast-scan cyclic voltammetry was used in nucleus accumbens core brain slices to determine alterations in dopamine terminal function, including release and uptake kinetics, and sensitivity to quinpirole (D2/D3 dopamine receptor agonist) and U50,488 (kappa opioid receptor agonist) induced inhibition of dopamine release. RESULTS: Ethanol drinking greatly increased uptake rates, which were positively correlated with lifetime ethanol intake. Furthermore, the sensitivity of dopamine D2/D3 autoreceptors and kappa opioid receptors, which both act as negative regulators of presynaptic dopamine release, was moderately and robustly enhanced in ethanol drinkers. CONCLUSIONS: Greater uptake rates and sensitivity to D2-type autoreceptor and kappa opioid receptor agonists could converge to drive a hypodopaminergic state, characterized by reduced basal dopamine and an inability to mount appropriate dopaminergic responses to salient stimuli. Together, we outline the specific alterations to dopamine signaling that may drive ethanol-induced hypofunction of the dopamine system and suggest that the dopamine and dynorphin/kappa opioid receptor systems may be efficacious pharmacotherapeutic targets in the treatment of alcohol use disorders.
RATIONALE: Hypofunction of striatal dopamine neurotransmission, or hypodopaminergia, is a consequence of excessive ethanol use and is hypothesized to be a critical component of alcoholism, driving alcohol intake in an attempt to restore dopamine levels; however, the neurochemical mechanisms involved in these dopaminergic deficiencies are not fully understood. OBJECTIVE: Here we examined the specific dopaminergic adaptations that produce hypodopaminergia and contribute to alcohol use disorders using direct, sub-second measurements of dopamine signaling in nonhuman primates following chronic ethanol self-administration. METHODS: Female rhesus macaques completed 1 year of daily (22 h/day) ethanol self-administration. Subsequently, fast-scan cyclic voltammetry was used in nucleus accumbens core brain slices to determine alterations in dopamine terminal function, including release and uptake kinetics, and sensitivity to quinpirole (D2/D3 dopamine receptor agonist) and U50,488 (kappa opioid receptor agonist) induced inhibition of dopamine release. RESULTS:Ethanol drinking greatly increased uptake rates, which were positively correlated with lifetime ethanol intake. Furthermore, the sensitivity of dopamine D2/D3 autoreceptors and kappa opioid receptors, which both act as negative regulators of presynaptic dopamine release, was moderately and robustly enhanced in ethanol drinkers. CONCLUSIONS: Greater uptake rates and sensitivity to D2-type autoreceptor and kappa opioid receptor agonists could converge to drive a hypodopaminergic state, characterized by reduced basal dopamine and an inability to mount appropriate dopaminergic responses to salient stimuli. Together, we outline the specific alterations to dopamine signaling that may drive ethanol-induced hypofunction of the dopamine system and suggest that the dopamine and dynorphin/kappa opioid receptor systems may be efficacious pharmacotherapeutic targets in the treatment of alcohol use disorders.
Authors: Christopher D Kroenke; Torsten Rohlfing; Byung Park; Edith V Sullivan; Adolf Pfefferbaum; Kathleen A Grant Journal: Neuropsychopharmacology Date: 2013-09-27 Impact factor: 7.853
Authors: Brett C Haberstick; Susan E Young; Joanna S Zeiger; Jeffrey M Lessem; John K Hewitt; Christian J Hopfer Journal: Drug Alcohol Depend Date: 2013-12-14 Impact factor: 4.492
Authors: A Ammendola; D Gemini; S Iannaccone; F Argenzio; G Ciccone; E Ammendola; L Serio; G Ugolini; F Bravaccio Journal: Alcohol Alcohol Date: 2000 Jul-Aug Impact factor: 2.826
Authors: Anushree N Karkhanis; Jamie H Rose; Kimberly N Huggins; Joanne K Konstantopoulos; Sara R Jones Journal: Drug Alcohol Depend Date: 2015-02-16 Impact factor: 4.492
Authors: Brian C Schweinsburg; Omar M Alhassoon; Michael J Taylor; Raul Gonzalez; John S Videen; Gregory G Brown; Thomas L Patterson; Igor Grant Journal: Am J Psychiatry Date: 2003-06 Impact factor: 18.112
Authors: Vanessa A Jimenez; Christa M Helms; Anda Cornea; Charles K Meshul; Kathleen A Grant Journal: Front Cell Neurosci Date: 2015-07-14 Impact factor: 5.505
Authors: V A Jimenez; M A Herman; V C Cuzon Carlson; N A Walter; K A Grant; M Roberto Journal: Neuropsychopharmacology Date: 2018-12-05 Impact factor: 7.853
Authors: Nancy J Alexander; Andrew R Rau; Vanessa A Jimenez; James B Daunais; Kathleen A Grant; Brian A McCool Journal: Alcohol Clin Exp Res Date: 2018-07-15 Impact factor: 3.455
Authors: Andrea Balla; Bin Dong; Borehalli M Shilpa; Kiran Vemuri; Alexandros Makriyannis; Subhash C Pandey; Henry Sershen; Raymond F Suckow; K Yaragudri Vinod Journal: Neuropharmacology Date: 2017-11-03 Impact factor: 5.250
Authors: Katherine M Holleran; Jamie H Rose; Steven C Fordahl; Kelsey C Benton; Kayla E Rohr; Paul J Gasser; Sara R Jones Journal: Eur J Neurosci Date: 2020-08-19 Impact factor: 3.386
Authors: Matthew A Weber; Eric T Graack; Jamie L Scholl; Kenneth J Renner; Gina L Forster; Michael J Watt Journal: Eur J Neurosci Date: 2018-07-10 Impact factor: 3.386